Glenmark Pharmaceuticals announced the FDA has approved Ryaltris, a fixed-dose (metered) combination nasal spray for the treatment of symptoms of Seasonal Allergic Rhinitis in adults…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.